TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hard to Treat Diseases
Hard To Treat Diseases (HTDS) Pending Merger Update
January 13th, 2009
Hard to Treat Diseases (HTDS) www.htdsmedical.com Further to the company's news release of December 30, 2008 where amongst other things the company addressed the targeted merger candidate, firstly the company is pleased to announce that it has appointed its new Chief Science Consultant. The director of research and business development for the company is Andrea Zecevic Rubio. Andrea is a University of Toronto graduate specializing in the field of Microbiology. Andrea has worked for Pasteur Meriuex Connaught Laboratories (Now Aventis) for several years as a microbiologist, before starting her own consulting business in the field of medical research, and software...
Source: TB & Outbreaks Week (2009-01-13)
|
